La disponibilidad de los productos en cada país depende de las aprobaciones de la Autoridad Sanitaria local y es posible que no estén disponibles para la venta en su mercado. Comunicados de Prensa VIEW ALL ϳԹ Partners with Imbio to Bring AI-based Patient Selection Tools to Customers with SeleCT™ QCT Analysis Service Feb 17, 2021 ϳԹ Partners with Imbio to Bring AI-based Patient Selection Tools to Customers with SeleCT™ QCT Analysis Service Feb 17, 2021 Live Remote Supervision of Neuroendovascular Surgery Enabled by ϳԹ MedPresence® Feb 11, 2021 iTind Temporary Implant Rapidly Relieves Enlarged Prostate, Preserves Sexual Function, Says Study Feb 4, 2021 ϳԹ PneumoLiner Is the Only 510(k)-Cleared Containment Device for Morcellation of Gynecological Tissue, as Recommended by the FDA Feb 3, 2021 ϳԹ PneumoLiner Is the Only 510(k)-Cleared Containment Device for Morcellation of Gynecological Tissue, as Recommended by the FDA Feb 3, 2021 ϳԹ Launches Comprehensive Global Educational Platform for Healthcare Professionals Feb 1, 2021 ϳԹ Launches Comprehensive Global Educational Platform for Healthcare Professionals Feb 1, 2021 ϳԹ to Acquire Quest Photonic Devices B.V. to Bolster Surgical Endoscopy Capabilities Jan 28, 2021 ϳԹ to Acquire Quest Photonic Devices B.V. to Bolster Surgical Endoscopy Capabilities Jan 28, 2021 Pagination First page « First Previous page ‹ Previous … áԲ 24 áԲ 25 áԲ 26 áԲ 27 áԲ 28 áԲ 29 áԲ 30 áԲ 31 áԲ 32 … Next page Next › Last page Last »
ϳԹ Partners with Imbio to Bring AI-based Patient Selection Tools to Customers with SeleCT™ QCT Analysis Service Feb 17, 2021
ϳԹ Partners with Imbio to Bring AI-based Patient Selection Tools to Customers with SeleCT™ QCT Analysis Service Feb 17, 2021
iTind Temporary Implant Rapidly Relieves Enlarged Prostate, Preserves Sexual Function, Says Study Feb 4, 2021
ϳԹ PneumoLiner Is the Only 510(k)-Cleared Containment Device for Morcellation of Gynecological Tissue, as Recommended by the FDA Feb 3, 2021
ϳԹ PneumoLiner Is the Only 510(k)-Cleared Containment Device for Morcellation of Gynecological Tissue, as Recommended by the FDA Feb 3, 2021
